| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥2.22B | +5.4% |
| Gross profit | ¥0.51B | — |
| Operating income | ¥0.05B | — |
| Net income | ¥0.06B | +26.3% |
| Gross margin | 23.0% | Net margin 2.6% |
| Revenue Q/Q | -62.8% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥1.71B | 77.0% |
| R&D | ¥0.09B | 4.2% |
| SG&A | ¥0.38B | 17.0% |
| Tax & other | ¥-0.01B | -0.6% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
神州泰岳 ・ 乐普医疗 ・ 南风股份 ・ 探路者 ・ 莱美药业 ・ 汉威科技 ・ 天海防务 ・ 安科生物 ・ ST豆神 ・ 鼎汉技术 ・ 华测检测 ・ 新宁物流
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies